Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

DCOY

Decoy Therapeutics Inc

May 13 • 04:00PM ET

4.82

-0.33 -6.41 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: BCDA PALI SHPH BIVI TNXP

| Held by: MEDX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-124.04	Insider Own	5.56%	Shs Outstand	0.53M	Perf Week	-19.80%
Market Cap	2.56M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	0.50M	Perf Month	-22.26%
Enterprise Value	-5.26M	PEG	-	EPS next Q	-	Inst Own	0.83%	Short Float	2.26%	Perf Quarter	-44.67%
Income	-13.03M	P/S	-	EPS this Y	-	Inst Trans	1.84%	Short Ratio	0.50	Perf Half Y	-79.92%
Sales	0.00M	P/B	0.66	EPS next Y	-	ROA	-242.20%	Short Interest	0.01M	Perf YTD	-38.09%
Book/sh	7.29	P/C	0.33	EPS next 5Y	-	ROE	-661.73%	52W High	415.80 -98.84%	Perf Year	-96.57%
Cash/sh	14.70	P/FCF	-	EPS past 3/5Y	81.80% 62.32%	ROIC	-336.14%	52W Low	5.09 -5.30%	Perf 3Y	-99.76%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	10.79% 8.41%	Perf 5Y	-99.99%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	86.68%	Oper. Margin	-	ATR (14)	0.52	Perf 10Y	-100.00%
Dividend Ex-Date	-	Quick Ratio	1.84	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	29.63	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.84	EPS Q/Q	97.74%	SMA20	-14.50%	Beta	0.38	Target Price	30.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-25.40%	Rel Volume	0.60	Prev Close	5.15
Employees	11	LT Debt/Eq	0.00	Earnings	Mar 30	SMA200	-83.11%	Avg Volume	22.60K	Price	4.82
IPO	Jan 29, 2015	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	13,526	Change	-6.41%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)